Suchergebnisse - "Fibrinolytic Agents"

PubPharm (55)

1

Bivalirudin versus heparin with primary percutaneous coronary intervention

enthalten in: American heart journal | 2018

von Venetsanos, D. | Lawesson, S. | James, S. | +4

2

Outcomes in elderly and young patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with bivalirudin versus heparin : Pooled analysis from the EUROMAX and HORIZONS-AMI trials

enthalten in: American heart journal | 2017

von Qaderdan, K. | Vos, G. | McAndrew, T. | +8

3

Single-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right ventricular dysfunction and myocardial injury : rationale and design of the Pulmonary Embolism Thrombolysis (PEITHO) trial

enthalten in: American heart journal | 2012

von Steering Committee | Konstantinides, S. | Meyer, G. | +26

4

Efficacy and safety of enoxaparin compared with unfractionated heparin in the pharmacoinvasive management of acute ST-segment elevation myocardial infarction : Insights from the TRANSFER-AMI trial

enthalten in: American heart journal | 2012

von Lavi, S. | Cantor, W. | Casanova, A. | +9

5

Heparin/PF4 antibodies formation after heparin treatment : temporal aspects and long-term follow-up

enthalten in: American heart journal | 2009

von Selleng, S. | Greinacher, A. | Ittermann, T. | +1

ErratumIn: Am Heart J. 2009 Oct;158(4):666

6

Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapy

enthalten in: American heart journal | 2008

von Chew, D. | Huang, Z. | Pieper, K. | +5

7

Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) trial

enthalten in: American heart journal | 2007

von Morrow, D. | Antman, E. | Murphy, S. | +7

8

Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials

enthalten in: American heart journal | 2007

von De Luca, G. | Marino, P.

9

The greatest benefit of enoxaparin over unfractionated heparin in acute coronary syndromes is achieved in patients presenting with ST-segment changes : the Enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) Electrocardiogram Core Laboratory Substudy

enthalten in: American heart journal | 2006

von Goodman, S. | Bozovich, G. | Tan, M. | +5

10

The vulnerable endothelium : priming the vascular endothelium for thrombosis with unfractionated heparin: biologic plausibility for observations from the Superior Yield of the New Strategy of Enoxaparin, Revascularization and GlYcoprotein IIb/IIIa Inhibitors (SYNERGY) trial

enthalten in: American heart journal | 2005

von Becker, R.

CommentIn: Am Heart J. 2006 May;151(5):e2. - PMID 16644303

1
2
3
4
5
6
Nächster »
[6]